comparemela.com

Latest Breaking News On - Ascension asset management - Page 6 : comparemela.com

Shelton Capital Management Has $5 20 Million Stock Holdings in Union Pacific Co (NYSE:UNP)

Shelton Capital Management raised its stake in shares of Union Pacific Co. (NYSE:UNP – Free Report) by 9.0% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 25,411 shares of the railroad operator’s stock after purchasing an additional 2,100 shares during the period. Shelton Capital Management’s holdings […]

Great Lakes Advisors LLC Sells 7,042 Shares of Lam Research Co (NASDAQ:LRCX)

Great Lakes Advisors LLC reduced its position in shares of Lam Research Co. (NASDAQ:LRCX – Free Report) by 23.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 23,254 shares of the semiconductor company’s stock after selling 7,042 shares during the period. Great Lakes Advisors […]

First Commonwealth Financial Corp PA Sells 131 Shares of Cummins Inc (NYSE:CMI)

First Commonwealth Financial Corp PA trimmed its holdings in shares of Cummins Inc. (NYSE:CMI – Free Report) by 6.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,756 shares of the company’s stock after selling 131 shares during the quarter. First Commonwealth […]

Linde plc (NYSE:LIN) Position Decreased by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC reduced its position in shares of Linde plc (NYSE:LIN – Free Report) by 17.6% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 320,508 shares of the basic materials company’s stock after selling 68,248 shares during the period. Linde […]

Ascension Asset Management LLC Purchases Shares of 6,393 Pfizer Inc (NYSE:PFE)

Ascension Asset Management LLC purchased a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 6,393 shares of the biopharmaceutical company’s stock, valued at approximately $234,000. Other institutional investors and hedge funds have also […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.